News and Events

Latest News

Arquer Diagnostics @Arquer Diagnostics
Recent #medicalstudies have highlighted a need for more research into #mentalhealth interventions for #patients #diagnosed with #urological #cancer, who are at an increased risk. Read more: https://t.co/5oflWPOCA3 https://t.co/CXLa3fVb49

- 17 days ago

1 1
Arquer Diagnostics @Arquer Diagnostics
The #clinical #research behind #ADXBLADDER is now described in the #EuropeanUrologyOncology Journal. Find out how effectively ADXBLADDER diagnoses bladder cancer here: https://t.co/ZiQRDmpBoM https://t.co/aLBewnK4qP

- 26 days ago

4 6
Arquer Diagnostics @Arquer Diagnostics
Protect your skin from the #Summer Sun and use #SPF 30 or higher to prevent #skin #cancer. Enjoy the Sun, safely! #Arquer #ArquerDiagnostics #health #diagnostics #sunsafety https://t.co/ZenWXfwM7U

- 30 days ago

Arquer Diagnostics @Arquer Diagnostics
#Innovation at #Arquer fuels our passion for #diagnostics. Our #ADXBLADDER is highly effective at detecting #cancer cells, so rapid and effective treatment can be given to patients early on. Let's #beatcancer together! https://t.co/kUTjbMEwVh https://t.co/uAx3qoctKI

- 36 days ago

1
Arquer Diagnostics @Arquer Diagnostics
Our #ADXBLADDER test allows #urologists to successfully monitor the recurrence of #bladder #cancer more effectively. Find out more: https://t.co/FhOvCtBxtO https://t.co/p3GvWoH3H1

- 45 days ago

2 2
arquer diagnostics

Innovation That Never Sleeps

The Start of Non-Invasive Testing When Arquer Diagnostics was set up to research and develop a new innovative urine test ...
Read More

Arquer Diagnostics achieves ISO13485 certification from BSI

In alignment with its commitment to achieving and maintaining excellence for patients, clinicians and all partners. BSI is an internationally ...
Read More

ADXBLADDER: A Novel Non-Invasive Aid for Bladder Cancer Monitoring

The innovative Arquer Diagnostic urine test for bladder cancer adds recurrence monitoring to the approved indications Sunderland, January 22nd 2019 ...
Read More

Arquer CEO Nadia Whittley Named Among Top 50 Female ‘Movers & Shakers’ in BioBusiness Report

Arquer Diagnostics Ltd (“Arquer”), a UK-based company focusing on the development of non-invasive cancer diagnostic tests today announced that CEO ...
Read More